Abstract Background Coronavirus disease 2019 (COVID-19) can involve persistence,
sequelae, and other clinical complications that last weeks to months to evolve into long …

Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …

Background Systemic corticosteroids are used to treat people with COVID‐19 because they
counter hyper‐inflammation. Existing evidence syntheses suggest a slight benefit on …

Long COVID, or post‐acute COVID‐19 sequelae, is experienced by an estimated one in
eight adults following acute COVID‐19. Long COVID is a new and complex chronic health …

Introduction Over three years have passed since the emergence of coronavirus disease
2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome …

Acute respiratory distress syndrome (ARDS) is frequently associated with sepsis. ARDS and
sepsis exhibit a common pathobiology, namely excessive inflammation. Corticosteroids are …

Introduction Drug repositioning is a strategy to identify a new therapeutic indication for
molecules that have been approved for other conditions, aiming to speed up the traditional …

Background The novel coronavirus disease 2019 (COVID-19) presents with complex
pathophysiological effects in various organ systems. Following the COVID-19, there are …

Background In SARS-CoV-2 infection, cytokines and laboratory biomarkers play a key role
in disease progression and their long-term levels have been associated with the outcome of …

Post-acute COVID-19 syndrome (PACS) is characterized by the persistence of one or more
symptoms after the acute phase, leading to physical disabilities. This study aims to …